1Klapper LN,Kirschbaum MH, Sela M,et al. Biochemical and clinical implication of ErbB/HER signaling network of growth factor receptor[J]. Adv Cancer Res, 2000, 77:25
2Lewis TS, Shapiro PS, Abn NG. Signal transduction through MAP kinase cascades[J]. Adv Cancer Res, 1998,74:139
3Salomon PS, Brandt R, Ciardiello F, et al. Epidermal growth factor-related peptides and their receptor in human malignancies[J]. Crit Rev Oncol Hematol, 1995,19:183
4Korc M,Chandrasekar B,Yamanaka Y, et al. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha[J]. J Clin In
5He Y,Zeng Q,Drenning SD,et al. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from thr u6 promoter[J]. J Natl Cancer Inst, 1998,90:1080
6Pietras RJ, Poen JC,Gallardo D, et al. Monoclonal antibody to HER-2/neu receptor modulates repair of radiation-induced DNA damage and enhance radiosensitivity of human breast cancer cells overexpressing this oncogene[J]. Cancer Res,1999,59:1347
7Baselga J,Norton L,Albanell J,et al. Recombinant humanized anti-HER2 antibody(Herceptin) enhances the antitumor activity of Paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts[J]. Cancer Res,1998,58 : 2825
8Perrotte P, Matsukmoto T, Inoue K, et al. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growth orthotopically in nude mice[J]. Clin Cancer Res, 1999,5: 257
9Fan Z, Mendelsohn J. Therapeutic application of antigrowth factor receptor antibodies[J]. Curr Opin Oncol, 1998,10:67
10Yang XD, Jia XC, Corvalan JRF, et al. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomoitant chemotherapy[J]. Cancer Res, 1999,59:1236
5Ciardicllo F,Tortora G.A novel approach in the treatment of cancer:targeting the epidermal growth factor receptor[J].Clin Cancer Res,2001,7(3):2958-2970.
6Baselga J.Why the epidermal growth factor receptor?[J].Oncologist,2002,7(4):2-8.
7Herbst RS,Giacone G,Schiller JH,et al.Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer:a phase Ⅲ trial-INTACT2[J].J Clin 0ncol,2004,22(5):785-784.
8Giaccone G,Herbst RS,Manegold C,et al.Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:a phase Ⅲ trial 2 intact1[J].J Clin Oncol,2004,22(9):777-784.
9Bonner JA,Raish KP,Trummell HQ,et al.Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers[J].J Clin Oncol,2000,18(21):47-53.
10Slichenmyer WJ,Fry DW.Anticancer therapy targeting in erbB family of receptor tyrosine kinase[J].Semin Oncol,2001,28 (16):67-79.
